Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.
about
Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention.Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.Vaginal microbiota and susceptibility to HIV.Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women.
P2860
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Efficacy of oral pre-exposure ...... ontrolled Partners PrEP Study.
@en
type
label
Efficacy of oral pre-exposure ...... ontrolled Partners PrEP Study.
@en
prefLabel
Efficacy of oral pre-exposure ...... ontrolled Partners PrEP Study.
@en
P2093
P2860
P50
P1433
P1476
Efficacy of oral pre-exposure ...... ontrolled Partners PrEP Study.
@en
P2093
Jairam Lingappa
James Kiarie
Jared M Baeten
Matthew Munch
Nelly Mugo
Partners PrEP Study Team
R Scott McClelland
Renee Heffron
Tina Fiedler
P2860
P304
P356
10.1016/S2352-3018(17)30110-8
P577
2017-07-18T00:00:00Z